RPL7A and malignant colon neoplasm: Our analysis showed that the upregulation of RPL7A, UBA52, UBB and UBC was commonly associated with all the top significant pathways in MS17-treated SW480 cells, suggesting the importance of these DEPs underlying the molecular mechanisms of MS17 to target signaling pathways and induce anti-cancer effects in colon cancer cells.